Over its two editions, The New Oxford Textbook of Psychiatry has come to be regarded as one of the most popular and trusted standard psychiatry texts among psychiatrists and trainees. Bringing together 146 chapters from the leading figures in the discipline, it presents a comprehensive account of clinical psychiatry, with reference to its scientific basis and to the patient's perspective throughout.
The New Oxford Textbook of Psychiatry, Third Edition has been extensively re-structured and streamlined to keep pace with the significant developments that have taken place in the fields of clinical psychiatry and neuroscience since publication of the second edition in 2009. The new edition has been updated throughout to include the most recent versions of the two main classification systems—-the DSM-5 and the ICD-11—-used throughout the world for the diagnosis of mental disorders.
In the years since publication of the first edition, many new and exciting discoveries have occurred in the biological sciences, which are having a major impact on how we study and practise psychiatry. In addition, psychiatry has fostered closer ties with philosophy, and these are leading to healthy discussions about how we should diagnose and treat mental illness. This new edition recognises these and other developments.
Throughout, accounts of clinical practice are linked to the underlying science, and to the evidence for the efficacy of treatments. Physical and psychological treatments, including psychodynamic approaches, are covered in depth. The history of psychiatry, ethics, public health aspects, and public attitudes to psychiatry and to patients are all given due attention.
An established and highly-praised textbook of psychiatry which has come to be regarded as one of the most popular and trusted standard psychiatry texts among psychiatrists and trainees.
Written and edited by the foremost international authorities, it presents a comprehensive account of clinical psychiatry, with reference to its scientific basis and to the patient's perspective throughout.
Integrates biological, psychological, and social approaches, providing the broadest possible coverage of the field.
Sections on treatment combine an evidence-based approach with practical advice based on extensive clinical experience.
New to this Edition:
Extensively re-structured and streamlined to keep pace with significant developments that have taken place in the fields of clinical psychiatry and neuroscience since publication of the second edition in 2009.
Updated throughout to include the most recent versions of the two main classification systems used throughout the world for the diagnosis of mental disorders, the DSM-5 and the ICD-11.
Guy M. Goodwin, Senior Research Fellow at the University of Oxford and the Past-President of the European College of Neuropsychopharmacology (ECNP) joins the editor team.
The list of sections and chapter topics has been completely reorganized in order to follow the "lifespan approach" to management of mental disorders and to eliminate repetition/overlap.
The total number of chapters has been reduced from 271 in the Second Edition to 146 in the Third Edition, whereas the number of sections has increased from 11 to 24. The print edition has been streamlined from 2 volumes to 1 volume.
Table of Contents
Section 1: The subject matter and approach to psychiatry
1: The patient's perspective, Kay Redfield Jamison and Adam Ian Kaplin
2: Public attitudes and the challenge of stigma, Nicole Votruba, Mirja Koschorke, and Graham Thornicroft
3: Global mental health, Crick Lund, Dörte Bemme, and Judy Bass
4: The history of psychiatry as a medical specialty, Pierre Pichot
5: A new ethics for 21st century psychiatry, Ilina Singh, Julian Savulescu, and Matthew L. Baum
6: Foundations of phenomenology / descriptive psychopathology, Hans-Jürgen Möller
7: DSM-5 and ICD-11 classifications, Darrel A. Regier, David P. Goldberg, Geoffrey M. Reed and Bedirhan T. Ustun
8: The National Institute of Mental Health Research Domain Criteria: An alternative framework to guide psychopathology research, Charles A. Sanislow, Sarah E. Morris, Jennifer Pacheco, and Bruce N. Cuthbert
9: Application of research evidence in clinical practice, Andrea Cipriani, Stefan Leucht, and John R. Geddes
10: A neuroscience based nomenclature for psychotropic drugs, Guy M. Goodwin, Joseph Zohar, and David J. Kupfer
Section 2: The scientific basis of psychiatric aetiology and treatment
11: Neuroanatomy, Karl Zilles and Nicola Palomero-Gallagher
12: Neuroimaging technologies, Mark Woolrich, Mark Jenkinson, and Clare Mackay
13: The connectome, Olaf Sporns
14: Neurotransmitters and signalling, Trevor Sharp
15: Psychoneuroimmunology, Juan C. Leza, Javier R. Caso, and Borja García-Bueno
16: Functional genomics, Caleb Webber
17: Cognitive neuroscience: Principles and methods, Anna Christina Nobre
18: Ageing and the human brain, Verena Heise, Enik? Zsoldos, and Klaus P. Ebmeier
19: Development of brain stimulation, Helen S. Mayberg, Andrea Cowell, and Patricio Riva Posse
20: Adherence to treatment in psychiatry, Amy Chan and Rob Horne
Section 3: Intellectual disabilities
21: Core dimensions of intellectual disabilities, Anthony J. Holland
22: Epidemiology and course of intellectual disabilities, Sally-Ann Cooper
23: Aetiology of intellectual disability: General issues and prevention, Judith L. Rapoport, Dale Zhou, and Kwangmi Ahn
24: Management and treatment of intellectual disability, José-Luis Ayuso-Mateos and Cary S. Kogan
Section 4: Autism spectrum disorders
25: Core dimensions of autism spectrum disorders, Fred R. Volkmar and Scott L. J. Jackson
26: Basic mechanisms and treatment targets for autism spectrum disorders, Emily J. H. Jones
27: Epidemiology of autism, Charles R. Newton
28: Genetics of autism spectrum disorders, Abha R. Gupta, Thomas V. Fernandez, and Ellen J. Hoffman
29: Imaging of autism spectrum disorders, Christine Eckera and Declan Murphy
30: Management and treatment of autism spectrum disorders, Emily Simonoff
Section 5: Attention deficit and hyperactivity disorder
31: Core dimensions of attention deficit hyperactivity disorder, Eric Taylor
32: Basic mechanisms and treatment planning / targets for attention deficit hyperactivity disorder, Barbara Franke and Jan K. Buitelaar
33: Epidemiology of attention deficit hyperactivity disorder and the implications for its prevention, Guilherme V. Polanczyk
34: Genetics of attention deficit hyperactivity disorder, Kate Langley and Anita Thapar
35: Insights from neuroanatomical imaging into attention deficit hyperactivity disorder throughout the lifespan, Philip Shaw and Eszter Szekely
36: Management and treatment of attention deficit hyperactivity disorder, Alessandro Zuddas and Sara Carucci
Section 6: Motor disorders
37: Neurodevelopmental motor disorders, Davide Martino and Antonella Macerollo
Section 7: Delirium, dementia, and other cognitive disorders
38: Pathways of neurodegeneration underlying dementia, Noel J. Buckley and George K. Tofaris
39: Delirium, Ravi S. Bhat and Kenneth Rockwood
40: Alzheimer's disease, Ivan Koychev and John Gallacher
41: Frontotemporal dementias, Akitoshi Takeda and Bruce Miller
42: Prion disease, Akin Nihat, TzeHow Mok, and John Collinge
43: Dementia with Lewy bodies, Anto P. Rajkumar and Dag Aarsland
44: Dementia in Parkinson's disease, Michele Hu and Fahd Baig
45: Dementia due to Huntington's disease, Russell L. Margolis
46: Vascular cognitive impairment, Joanne A. Byars and Ricardo E. Jorge
47: Traumatic brain injury, Christian Lepage, Inga K. Koerte, Vivian Schultz, Michael J. Coleman, and Martha E. Shenton
Section 8: Substance use disorders
48: Substance use disorders and the mechanisms of drug addiction, Trevor W. Robbins and Barry J. Everitt
49: Genetics of substance use disorders, Yann Le Strat, Nicolas Ramoz, and Philip Gorwood
50: Alcohol use disorder, Wim van den Brink and Falk Kiefer
51: Opiates: Heroin, methadone, buprenorphine, Michael Farrell, Briony Larance, and Courtney Breen
52: Cannabis and mental illness, David J. Castle
53: Stimulants, ecstasy, and other party drugs, Adam R. Winstock and Remy Flechais
54: Psychedelics and dissociative substances, Adam Winstock and James Rucker
55: Tobacco addiction, Marcus Munafo and Meryem Grabski
56: Co-morbidity of substance use and psychiatric disorders, Julia M. A. Sinclair and Anne Lingford-Hughes
Section 9: Schizophrenia and psychotic disorders
57: The core dimensions of schizophrenia, Nancy C. Andreasen
58: Epidemiology and course of schizophrenia, Assen Jablensky
59: Genetics of schizophrenia, Kimberley M. Kendall, James T. R. Walters and Michael C. O Donovan
60: Structural and functional neuroimaging of schizophrenia, Andreea O. Diaconescu, Sandra Iglesias, and Klaas E. Stephan
61: Schizoaffective and schizotypal disorders / acute and transient psychotic disorders, William S. Stone, Stephen V. Faraone and Ming T. Tsuang
62: Delusional disorders, Andreas Marneros
63: Prevention and early intervention in psychotic disorders, Emre Bora, Mahesh Jayaram, and Christos Pantelis
64: Antipsychotic and anticholinergic drugs, Herbert Y. Meltzer and William V. Bobo
65: The treatment and management of patients with schizophrenia, Joseph P. McEvoy, Kammarauche Asuzu, Daniel W. Bradford, Oliver Freudenreich, and Katherine Moyer
Section 10: Mood disorders
66: Diagnosis, classification and differential diagnosis of mood disorders, S. Nassir Ghaemi and Sivan Mauer
67: Epidemiology of mood disorders, Lars Vedel Kessing
68: Primary prevention of mood disorders: Building a target for prevention strategies, Gin S. Malhi
Section 11: Bipolar disorder
69: Basic mechanisms of and treatment targets for bipolar disorder, Grant C. Churchill, Nisha Singh, and Michael J. Berridge
70: Genetics of bipolar disorder, Francis J. MacMahon and Sevilla Detera-Wadlieigh
71: Neuroimaging of bipolar disorder, Mary L. Phillips and Wayne C. Drevets
72: Management and treatment of bipolar disorder, Eduard Vieta, Isabella Pacchiarotti, and David J. Miklowitz
73: Perinatal psychiatry, Ian Jones and Arianna Di Florio
Section 12: Depressive disorders
74: Basic mechanisms of and treatment targets for depressive disorders, Marcela Pereira, Roberto Andreatini, and Per Svenningsson
75: Genetic epidemiology of depression in the molecular era, Alison K. Merikangas and Kathleen R. Merikangas
76: Imaging of depressive disorders, Guy M. Goodwin and Michael Browning
77: Management and treatment of depressive disorders, Philip J. Cowen
Section 13: Trauma and stress or related and adjustment disorders
78: Classification and descriptive psychopathology of posttraumatic stress disorder and other stressor-related disorders, Dean G. Kilpatrick, Matthew J. Friedman, and Amanda K. Gilmore
79: Basic mechanisms of and treatment targets for stress-related disorders, Bruce S. McEwen
80: Genetics of stress-related disorders, Michael G. Gottschalk and Katharina Domschke
81: Imaging of stress-related disorders, Navneet Kaur, Cecilia Hinojosa, Julia Russell, Michael B. Van Elzakker, and Lisa M. Shin
82: Primary prevention and epidemiology of trauma and stress related disorders, Maria Bragesjö, Emily A. Holmes, Filip Arnberg, and Erik M. Andersson
83: Management and treatment of stress-related disorders, Leigh van den Heuvel and Soraya Seedat
84: Bereavement, Beverley Raphael, Sally Wooding, and Julie Dunsmore
85: Recovered memories and false memories, Deborah Davis and Elizabeth F. Loftus
Section 14: Anxiety disorders
86: Core dimensions of anxiety disorders, Nastassja Koen and Dan J. Stein
87: Basic mechanisms, genetics, targets and animal models for anxiety disorders, Martien Kas and Berend Olivier
88: Epidemiology and course of anxiety disorders, Hans-Ulrich Wittchen and Katja Beesdo-Baum
89: Genetics of anxiety disorders, Michael G. Gottschalk and Katharina Domschke
90: Neuroimaging of anxiety disorders, Gregor Leicht and Christoph Mulert
91: The primary prevention of anxiety disorders, Aliza Werner-Seidler, Jennifer L. Hudson, and Helen Christensen
92: Treatment of anxiety disorders, David S. Baldwin and Nathan T. M. Huneke
Section 15: Obsessive-compulsive and related disorders
93: Core dimensions of obsessive-compulsive disorder, Sophie C. Snyder, Eric A. Storch, and Wayne K. Goodman
94: Basic mechanisms of and treatment / planning targets for obsessive-complusive disorder, Eric Burguière and Luc Mallet
95: Obsessive-compulsive disorder, Lior Carmi, Naomi A. Fineberg, Oded Ben-Arush, and Joseph Zohar
96: Genetics of obsessive-compulsive disorder, Gerald Nestadt and Jack Samuels
97: Imaging of obsessive-compulsive disorder, Rebbia Shahab and Emily R. Stern
98: Management and treatment of obsessive-compulsive disorder, Naomi A. Fineberg, Lynne M. Drummond, Jemma Reid, Eduardo Cinosi, Lior Carmi, and Davis N. Mpavaenda
99: Hoarding disorder, Lorena Fernández de la Cruz and David Mataix-Cols
100: Body dysmorphic disorder, Megan M. Kelly and Katharine A. Phillips
Section 16: Feeding and eating disorders
101: The eating disorders, Chris Fairburn and Rebecca Murphy
102: Basic mechanisms and potential for treatment of weight and eating disorders, Johannes Hebebrand, Jochen Antel, and Beate Herpertz-Dahlmann
103: Epidemiology and primary prevention of feeding and eating disorders, Katherine A Halmi
104: Genetics of feeding and eating disorders, Christopher Hüble, Cynthia Bulik, and Gerome Breen
105: Imaging of feeding and eating disorders, Natalie Kurniadi, Christina E. Wierenga, Laura A. Berner, and Walter H. Kaye
106: Management and treatment of feeding and eating disorders, Susan L. McElroy, Anna I. Guerdjikova, Nicole Mori, Paul L. Houser, and Paul E. Keck, Jr.
107: Aetiology and management of obesity, Jamie Hartmann-Boyce, Nerys M. Astbury, and Susan A. Jebb
108: Elimination disorders in children and adolescents, Alexander von Gontard
Section 17: Sleep wake disorders
109: Basic mechanisms of and treatment targets for sleep-wake disorders, David Pritchett, Angus S. Fisk, Russell G. Foster, and Stuart N. Peirson
110: Diagnosis of sleep and circadian rhythm disorder, Kirstie Anderson
111: Epidemiology of sleep-wake and primary prevention of its disorders, Lena Katharina Keller, Eva C. Winnebeck, and Till Roenneberg
112: Genetics of sleep-wake disorders, Diego R. Mazzotti, Allan I. Pack, and Philip R. Gehrman
113: Multi-modal imaging of sleep-wake disorders, Umberto Moretto, Dylan Smith, Liliana Dell Osso, and Thien Thanh Dang-Vu
114: Management of insomnia and circadian rhythm sleep-wake disorders, Simon D. Kyle, Alasdair L. Henry, and Colin A. Espie
Section 18: Sexual function and sexual dysfunction
115: The sexual dysfunctions and paraphilias, Cynthia A. Graham and John Bancroft
116: Gender dysphoria, Els Elaut and Gunter Heylens
Section 19: Personality disorders
117: Core dimensions of personality pathology, Andrew E. Skodol and Leslie C. Morey
118: Basic mechanisms of and treatment planning / targets for personality disorders, Kate E. A. Saunders and Steve Pearce
119: Personality disorders: Epidemiology and clinical course, Renato D. Alarcón and Brian A. Palmer
120: Genetics of personality disorders, C. Robert Cloninger
121: Imaging of personality disorders, Christian Paret and Christian Schmahl
122: Treatment and management of personality disorder, Giles Newton-Howes and Roger Mulder
Section 20: Impulse control and conduct disorders
123: Impulse control and its disorders: including pathological gambling, Donald W. Black
124: Conduct disorders and antisocial personality disorder in childhood and adolescence, Stephen Scott and Melanie Palmer
Section 21: Suicide
125: Epidemiology and causes of suicide, Merete Nordentoft, Trine Madsen, and Annette Erlangsen
126: Self-harm: Epidemiology and risk factors, Nav Kapur, Sarah Steeg, and Adam Moreton
127: Biological aspects of suicidal behaviour, J. John Mann and Dianne Currier
128: Prevention of suicide and treatment following self-harm, Keith Hawton, Kate E. A. Saunders, and Alexandra Pitman
Section 22: Somatic symptoms and related disorders
129: Deconstructing dualism: The interface between physical and psychological illness, Michael Sharpe and Jane Walker
130: Neural mechanisms in chronic pain relevant for psychiatric interventions, Chantal Berna and Irene Tracey
131: Treatment of fibromyalgia (chronic widespread pain) and chronic fatigue syndrome, Jonathan Price
132: Factitious disorder and malingering, Thomas Merten and Harald Merckelbach
133: Functional neurological symptom disorder (Conversion disorder), Jon Stone and Michael Sharpe
Section 23: Service provision
134: Public policy and service needs in mental health, Martin Knapp
135: Planning and providing mental health services for a community, Tom Burns and Tony Kendrick
136: Health economic analysis of service provision, Judit Simon
137: The organization of psychiatric services for general hospital departments: Proactive and preventive interventions in psychiatry, William H. Sledge and Julianne Dorset
138: Refugees and populations exposed to mass conflict, Mina Fazel, Susan Rees, and Derrick Silove
Section 24: Forensic psychiatry
139: Associations between psychiatric disorder and offending, Seena Fazel and Mark Toynbee
140: Developmental approach to understanding the needs of young people in contact with the criminal justice system, Sue Bailey and Prathiba Chitsabesan
141: Child molesters and other sexual offenders, Stephen J. Hucker
142: Stalking and querulous behaviour, Rosemary Purcell and Paul E. Mullen
143: Domestic violence and abuse and mental health, Louise M. Howard and Deirdre MacManus
144: Assessing and managing the risk of violence towards others, Alec Buchanan
145: The expert witness in the criminal and civil courts, John O Grady
146: Homicide, Matthew Large and Olav Nielssen
